There were 146 press releases posted in the last 24 hours and 437,672 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GSK and Theravance announce initiation of phase III programme with fixed dose triple combination treatment FF/UMEC/VI in patients with COPD

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image